Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

IFIH1 and developmental delay are reported together in 2 articles.

Gene

IFIH1

HGNC
HGNC:18873
8articles
8mentions
2variants with confirmed gene link
Most co-reported phenotypes (articles)
Reported variants (articles · ClinVar status)
HPO
HP:0001263
480articles
480mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

2 records shown · first 60

Monogenic interferon-mediated diseases: novel phenotype and genotype characteristics from a Saudi population.

PMID 38976295 | DOI 10.55563/clinexprheumatol/aa6drm · Clinical and experimental rheumatology · 2024 · 10 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneIFIH1“Eight patients were diagnosed with Aicardi-Goutières syndrome, attributed to variants in the RNASEH2A, RNASEH2C, and IFIH1 genes.”0.98hgnc_dict_v1
phenotypedevelopmental delay“Despite these interventions, a partial response to treatment was observed, and cumulative disease damage primarily manifested as growth failure and developmental delay.”0.98phenotype_alias_lexicon_v2
geneRNASEH2A“Eight patients were diagnosed with Aicardi-Goutières syndrome, attributed to variants in the RNASEH2A, RNASEH2C, and IFIH1 genes.”0.98hgnc_dict_v1
geneRNASEH2C“Eight patients were diagnosed with Aicardi-Goutières syndrome, attributed to variants in the RNASEH2A, RNASEH2C, and IFIH1 genes.”0.98hgnc_dict_v1

Phenotypic and Molecular Spectrum of Aicardi-Goutières Syndrome: A Study of 24 Patients.

PMID 29239743 | DOI 10.1016/j.pediatrneurol.2017.09.002 · Pediatric neurology · 2018 · 14 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneIFIH1“Homozygous mutations were identified in RNASEH2B (54.2%), RNASEH2A (20.8%), RNASEH2C (8.3%), SAMHD1 (8.3%), TREX1 (4.2%), and heterozygous mutations in IFIH1 (4.2%), with c.356A>G (p.Asp119Gly) in RNASEH2B being the most frequent mutation.”0.98hgnc_dict_v1
phenotypedevelopmental delay“Patients presented with developmental delay (24 cases, 100%); spasticity (24 cases, 100%); speech delay (23 cases, 95.8%); profound intellectual disability (21 cases, 87.5%); truncal hypotonia (21 cases, 87.5%); seizures (eighteen cases, 75%); and epileptic encephalopathy (15 cases, 62.5%).”0.98phenotype_alias_lexicon_v2
geneRNASEH2B“Homozygous mutations were identified in RNASEH2B (54.2%), RNASEH2A (20.8%), RNASEH2C (8.3%), SAMHD1 (8.3%), TREX1 (4.2%), and heterozygous mutations in IFIH1 (4.2%), with c.356A>G (p.Asp119Gly) in RNASEH2B being the most frequent mutation.”0.98hgnc_dict_v1
geneRNASEH2A“Homozygous mutations were identified in RNASEH2B (54.2%), RNASEH2A (20.8%), RNASEH2C (8.3%), SAMHD1 (8.3%), TREX1 (4.2%), and heterozygous mutations in IFIH1 (4.2%), with c.356A>G (p.Asp119Gly) in RNASEH2B being the most frequent mutation.”0.98hgnc_dict_v1